Page 53 - IJB-10-2

International Journal of Bioprinting Advancements in 3D printing

in producing limited-batch or large-scale personalized biological and mechanical impacts. Gazing ahead, we
medical devices, expanding from its initial role in in engage in speculation concerning the potential evolution
vitro device production. Its applications are now rapidly of 3D bioprinting technologies. Our projection envisions
growing to encompass individually customized permanent widespread adoption of these technologies across diverse
implants, clinical restorative interventions, and pioneering domains, especially for the fabrication of individualized
research endeavors in drug development. 3D bioprinting and heterogeneous intricate biological constructs. 3D
5
technologies have emerged as promising tools for creating bioprinting stands poised for applications spanning the
intricate 3D cell structures in vitro. However, there are generation of in vitro medical models, bespoke implantable
several common misconceptions surrounding these devices, scaffolds for tissue engineering, and elaborate 3D
technologies. Many people believe that 3D bioprinting cellular frameworks. Furthermore, it will wield a pivotal
can print any type of material and facilitate the production role in tailored diagnostics and therapeutics, customized
of transplantable organs, such as hearts, livers, kidneys, medical equipment, regenerative medicinal interventions,
and lungs. In reality, the original vision of 3D bioprinting and domains of investigation encompassing pathological
producing fully functional transplantable organs has and pharmacological inquiries, drug innovation, and
not been realized, and significant hurdles remain to be biopharmaceutical sector. On the whole, the forthcoming
overcome. Organs are significantly more complex than horizons for 3D bioprinting technologies radiate promise
6
commonly understood. Firstly, there is still much to and portend a revolution in the medical sector for years to
uncover about the intricate biological processes involved come.
in organ development. Secondly, reproducing the complex
architecture of organs presents substantial manufacturing 2. Overview of 3D bioprinting technologies
challenges. For instance, despite their seemingly simple
7
appearance, blood vessels comprise multiple layers with 2.1. Research progress of 3D bioprinting at home
diverse cell structures, and they possess properties such and abroad
as selective permeability, elasticity, and anticoagulation. In recent times, the advancements in artificial organ 3D
These factors make it extremely challenging to bioprint printing technology have garnered significant interest across
fully functional blood vessels in vitro to replace damaged diverse research fields. Numerous investigations have been
ones in vivo. undertaken in this domain. For example, Antezana et al.
harnessed micro-stereolithography technology to fabricate
Contemporary research in the realm of 3D bioprinting scaffolds for tissues. Jiang et al. devised a technique that
8
primarily concentrates on establishing a 3D biological incorporates graphene oxide (GO) and mesenchymal
environment in vitro to mimic in vivo conditions, and stem cells directly into gelatin methacryloyl (GelMA),
encompasses endeavors like high-throughput drug forming biocompatible scaffolds for bone regenerative
screening, organogenesis, and the study of pathological therapy. Furthermore, through 3D bioprinting, the
9
mechanisms. It is crucial to recognize, however, that decellularized extracellular matrix (dECM) is freeze-
creating tissues or organs in vitro is incapable of fully dried and subsequently reconstituted, then amalgamated
addressing the escalating scarcity of transplantable organs. with gelatin, alginate, and cells, yielding a novel form of
While it is feasible to manufacture cell-housing structures, biological scaffold. The United States is actively playing
these structures merely mimic the external appearance a spearheading role in the research and development of
and form of internal tissues and organs. The cells within 3D printing of artificial organs, and has initiated projects
these constructs only exhibit fundamental collaborative focusing on the crafting of 3D breast cancer tissue models,
functions, falling short of the intricate physiological cell printing for wound healing, and the fusion of microliver
operations showcased by real organs. This conundrum simulations with cell constructs. Esteemed institutions such
epitomizes the major challenge confronting 3D bioprinting as the Massachusetts Institute of Technology (MIT) are at
technologies today. the forefront of this field, concentrating notably on cell 3D
This paper furnishes an overarching review of the printing and organ bioprinting. Several medical research
evolution, categorization, and utilization of 3D bioprinting organizations and enterprises have also made significant
technologies, emphasizing the foundational principles strides utilizing 3D printing technology to fabricate human
of 3D printing. Additionally, we introduce biological organs and tissues, including arteries, cardiac tissue, lungs,
materials that harmonize with 3D printing. However, the and kidneys. In addition, Koch et al. have corroborated
current research landscape predominantly encompasses the viability of 3D printing for tissue regeneration. The
10
a limited spectrum of biological materials, whereas rapidly evolving 3D printing technology for artificial organ
human tissues and organs, for the most part, comprise in China has surpassed the global standards. Researchers
intricate amalgamations of elements with specific from numerous Chinese universities and institutions have

Volume 10 Issue 2 (2024) 45 doi: 10.36922/ijb.1752